Navigation Links
FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women
Date:2/4/2011

SILVER SPRING, Md., Feb. 4, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery before 37 weeks of pregnancy, in pregnant women with a history of at least one spontaneous preterm birth.  

(Logo:  http://photos.prnewswire.com/prnh/20090824/FDALOGO)

The drug is not intended for use in women with a multiple pregnancy, such as a twin pregnancy, or other risk factors for preterm birth.  

The FDA approved Makena under the agency's accelerated approval regulations that allow promising drugs to be approved based on a surrogate endpoint benefit (here, reducing the risk of delivery before 37 weeks of pregnancy) that is reasonably likely to predict a clinical benefit.

Under these regulations, the manufacturer must conduct additional studies after the product is approved to demonstrate that the drug does, in fact, have a clinical benefit.  An international trial is ongoing to learn if there is also improvement in the outcome of babies born to women given Makena. Such outcomes include reducing the number of babies who do not survive or who suffer serious health problems shortly after birth.  

"Preterm birth is a significant public health issue in the United States," said Sandra Kweder, M.D., deputy director of the Office of New Drugs in the FDA's Center for Drug Evaluation and Research. "This is the first drug approved by the FDA that is indicated to specifically reduce this risk."

A health care provider would give Makena once a week by injection into the hip. Treatment should begin at 16 weeks and no later than 21 weeks of pregnancy.

The FDA reviewed data on the safety and effectiveness of Makena in a multicenter randomized double-blind clinical trial. The study included 463 women 16 to 43 years of age who were pregnan
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Genomic Health, ... Kim Popovits , Chairman, Chief Executive Officer and President, ... Jaffray Healthcare Conference at The New York Palace Hotel ... December 3 at 11:30 am Eastern Time (ET). ... of the conference call, go to the  Investor Relations ...
(Date:11/26/2014)... , Nov. 26, 2014  Over 100 million ... those suffer from this pain daily. Chronic and acute ... pain management is born to fulfill the need for ... types of pain. On October 28th, a ... Cumberland, Maryland community.  This new ...
(Date:11/26/2014)... Oregon , November 26, 2014 ... fascia of the organ protrudes through the wall of a ... muscle area at birth are some of the causes of ... umbilical, hiatal, femoral, and incisional. An inguinal hernia is when ... An umbilical hernia is found in the area of the ...
Breaking Medicine Technology:Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3New Pain Management Center Opens in Cumberland, Md. 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4
... Mass., Oct. 11, 2011 Merrimack Pharmaceuticals, Inc. ... dosed in a randomized Phase 2 clinical trial ... targets ErbB3, combined with paclitaxel (Taxol®) in the ... (Logo: http://photos.prnewswire.com/prnh/20100913/NE63515LOGO) The Phase 2 ...
... BEIJING, Oct. 11, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, ... leading China-based advanced in-vitro diagnostic ("IVD") company, today announced ... Kingdom Intellectual Property Office (the "UKIPO") and Notice of ... Patent and Trademark Office (the "USPTO"). All patents relate ...
Cached Medicine Technology:Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients 2China Medical Technologies Receives Two Patents Granted by the UKIPO and Notice of Allowance for Four Patent Applications from the USPTO 2China Medical Technologies Receives Two Patents Granted by the UKIPO and Notice of Allowance for Four Patent Applications from the USPTO 3
(Date:11/28/2014)... THURSDAY, Nov. 27, 2014 (HealthDay News) -- Celebration ... are misused on Thanksgiving Day, experts say. Over ... hot-oil burns have occurred while people were using turkey ... "I have actually cared for a patient who ... should not be done in any circumstances," Dr. Arthur ...
(Date:11/28/2014)... November 28, 2014 PreDiabetes ... and treatment, helped employees learn their risk for ... blood screening at a local school in partnership ... Work initiative. , As the Presenting Sponsor ... , PreDiabetes Centers is co-hosting diabetes-prevention presentations at ...
(Date:11/28/2014)... New York, New York (PRWEB) November 28, 2014 ... lawsuits ( http://www.consumerinjurylawyers.com/stryker-rejuvenate/stryker-hip-lawsuits/ ) have now been filed ... pair of recalled metal implants, Bernstein Liebhard LLP ... November 18th in Bergen County Superior Court reflects ... and ABG II modular-neck hip stems, which were ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Patten Pecans, ... locally grown. With those passions driving them, they've added ... Grown. Having tried other pecans oils, they've found this ... Georgia to be exceptionally flavorful, retaining the buttery pecan ... same nutritional benefits found in pecans nuts ...
(Date:11/28/2014)... Before that Thanksgiving meal even had time to digest, ... season. Today, people will stand in line for hours to ... shopping day of the year. , But instead of ... dentist Dr. Ronald Receveur is asking the public to ... brighten a few smiles. , The gifts he suggests are:, ...
Breaking Medicine News(10 mins):Health News:Turkey Fryer Mishaps Can Cause Serious Burns 2Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 3Health News:Patten Pecans Goes Local with Nutritious Georgia Pecan Oil 2Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 2Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 3Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 4
... type of skin cancer. In this paper, Leif Ellisen and ... and p73 in SCC cells, and discovered a feedback loop ... SCC, they found that inhibiting one of these miRs decreased ... highlighting a new potential therapeutic target. , Squamous cell carcinoma ...
... Reinberg HealthDay Reporter , SUNDAY, Jan. 9 ... (best known by the brand name of Prozac) appear ... sufferers, French researchers have found. Not surprisingly, patients ... depression after their stroke, the study found. Paralysis ...
... The search for a universal flu vaccine has received a ... strain. Several patients infected with the 2009 H1N1 strain ... strains, scientists from Emory University School of Medicine and the ... Monday in the Journal of Experimental Medicine . ...
... Hope for new ways of treating devastating neurodegenerative disorders ... trans-Atlantic team of researchers thanks to the use of ... Leicester, scientists from the University of Lisbon (led by ... Francisco (led by Dr Paul Muchowski) collaborated to generate ...
... areas of the United States are more likely to ... areas, particularly when comparing non-whites living in different parts ... new study published early online in Cancer , ... research is needed to better understand how colorectal cancer ...
... (HealthDay News) -- The first study to focus solely on ... the Sept. 11, 2001 attacks on the World Trade Center ... fact, of the 3,271 evacuees of the Twin Towers surveyed ... from at least one current post-traumatic stress symptom, while 15 ...
Cached Medicine News:Health News:Prozac May Speed Physical Rehabilitation After Stroke 2Health News:Prozac May Speed Physical Rehabilitation After Stroke 3Health News:Pandemic flu strain could point way to universal vaccine 2Health News:Pandemic flu strain could point way to universal vaccine 3Health News:New hope in fight against Huntington's disease 2Health News:Race affects regional colorectal cancer screening disparities 2Health News:Many Survivors of World Trade Center Attacks Suffered PTSD: Study 2
... Cobas Integra 400 plus, innovation means ... of reaction cuvettes and im-proved operator ... menu and ease-of-use required for true ... only possible with only one analytical ...
... The Advia 1650 has ... (as low as 2 L/test), ... 80 L/test) and water consumption ... management efficiency. Optional universal rack ...
Iron UIBC (UIBC Buffer + Color + Std.). An Automated analyzer test kits....
HDL Cholesterol, liquid....
Medicine Products: